LONDON--(BUSINESS WIRE)--The global antibiotics market is poised to grow by USD 4.44 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. Request free sample pages
Read the 120-page report with TOC on "Antibiotics Market Analysis Report by Application (Antibiotics for human use and Antibiotics for veterinary use), Product (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), Drug Origin (Natural, Semi-synthetic, and Synthetic), Action mechanism (Bacteriostatic and Bactericidal), and Geographic segmentation (North America, APAC, Europe, South America, and MEA), and the Segment Forecasts, 2020-2024".
https://www.technavio.com/report/antibiotics-market-industry-analysis
The market is driven by the rising prevalence of infectious diseases. In addition, the growing awareness of various diseases and its treatment is anticipated to boost the growth of the antibiotics market.
The prevalence of infectious diseases, which are caused by pathogens is increasing around the world through direct and indirect contact between people. The major causes of infectious diseases include rapid urbanization and globalization along with favorable condition of growth, colonization, and transmission of these pathogens. Deforestation destroys our ecosystems and natural landscapes resulting in the movement of animals near human habitats. Often these animals are vectors for pathogen transmission. Lack of sanitation, poor living conditions, inadequate waste management systems, and growing number of dams are other factors responsible for the increasing number of individuals affected by infectious diseases. This is propelling the demand for antibiotics and urging key pharmaceutical companies to introduce effective antibiotics. Thus, the rising prevalence of infectious diseases is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Antibiotics Market Companies:
Abbott Laboratories
Abbott Laboratories operates the business under various segments such as Established Pharmaceuticals Products, Nutritional Products, Diagnostic Products, and Medical Devices. The company provides a range of antibiotic products including Cefditoren.
AbbVie Inc.
AbbVie Inc. offers products through the Pharmaceutical products business unit. The company focuses on the manufacturing and commercialization of drugs for the treatment of various indications. They provide a range of antibiotic products including Cefdinir.
AstraZeneca Plc
AstraZeneca Plc operates under the Biopharmaceuticals business segment. The company provides a range of antibiotic products including Merrem. They are involved in research activities and development of novel therapies for the treatment of various respiratory, cardiovascular, and oncology indications.
Bayer AG
Bayer AG offers products through the following business segments: Pharmaceuticals, Crop Science, Consumer Health, and Animal Health. The company provides a range of antibiotic products such as Ciprofloxacin.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. offers products through the following business segments: Pharmaceuticals and Diagnostics. The company provides a range of antibiotic products such as Bactrim. They are involved in manufacturing of essential drugs for diseases such as inflammatory diseases, metabolic and central nervous system disorders, and viral infections.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Antibiotics Market Application Outlook (Revenue, USD Billion, 2020-2024)
- Antibiotics for human use
- Antibiotics for veterinary use
Antibiotics Market Product Outlook (Revenue, USD Billion, 2020-2024)
- Broad-spectrum antibiotics
- Narrow-spectrum antibiotics
Antibiotics Market Drug Origin Outlook (Revenue, USD Billion, 2020-2024)
- Natural
- Semi-synthetic
- Synthetic
Antibiotics Market Action Mechanism Outlook (Revenue, USD Billion, 2020-2024)
- Bacteriostatic
- Bactericidal
Antibiotics Market Geographic Outlook (Revenue, USD Billion, 2020-2024)
- North America
- APAC
- Europe
- South America
- MEA
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
Periodontal Therapeutics Market – Global Periodontal Therapeutics Market by product (local antibiotics and systemic antibiotics) and geography (Asia, Europe, North America, and ROW).
Staphylococcal Infection Drugs Market – Global Staphylococcal Infection Drugs Market by product (beta-lactams, peptides, quinolones, macrolides, and others) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
